HT
TNDM icon

Headlands Technologies’s Tandem Diabetes Care TNDM Stock Holding History

Headlands Technologies’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,193
Closed -$602K – 1593
2024
Q3 		$602K Buy
14,193
+12,133
+589% +$514K 0.07% 305
2024
Q2 		$83K Buy
2,060
+1,079
+110% +$45K 0.01% 681
2024
Q1 		$34.7K Buy
+981
New +$26.3K 0.01% 796
2023
Q3 		– Sell
-549
Closed -$13.5K – 1209
2023
Q2 		$13.5K Buy
549
+314
+134% +$10.1K ﹤0.01% 600
2023
Q1 		$9.54K Buy
+235
New +$9.73K 0.01% 335

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Headlands Technologies's TNDM Position: Q4 2024 in Review

Headlands Technologies sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 14,193 shares — an estimated $602K sold.

Headlands Technologies first reported a position in TNDM in Q1 2023 and held it in 5 quarters. The position peaked at $602K in Q3 2024. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • Headlands Technologies reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • Headlands Technologies sold 14,193 Tandem Diabetes Care shares in Q4 2024, an estimated $602K.
  • Headlands Technologies first reported a position in Tandem Diabetes Care in Q1 2023 and held it in 5 quarters.
  • Headlands Technologies's Tandem Diabetes Care position peaked at $602K in Q3 2024.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Headlands Technologies's 13F filing for Q4 2024, filed 12 Feb 2025.